The cash received under the Facility, if received in full, creates expected cash runway intended to fund the business through 30 April, permitting a focus on the Monetization Process. The borrower under the Facility is Estetra SRL with a guarantee from Mithra Pharmaceuticals SA (such guarantee being limited in recourse to the secured assets). The Facility is secured on all of the assets of Estetra SRL, a share pledge over shares in Estetra SRL and a pledge on intercompany receivables of Mithra Pharmaceuticals SA on Estetra SRL. The maturity date of the Facility is sixty days from the first utilization date of the Facility. The initial conditions precedent have been met, and the first drawdown of EUR 9 million is expected to be drawn on 6 March 2024.